ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway

被引:12
|
作者
Xin, Ting [1 ]
Lv, Wei [1 ]
Liu, Dongmei [1 ]
Jing, Yongle [1 ]
Hu, Fang [1 ]
机构
[1] Tianjin First Cent Hosp, Dept Cardiol, Tianjin 300192, Peoples R China
来源
AGING-US | 2020年 / 12卷 / 12期
关键词
ROCK1; LATS2; JNK; NSCLC; apoptosis; OXIDATIVE STRESS; MITOCHONDRIAL FISSION; APOPTOSIS; INJURY; HIPPO; AXIS; JNK; CARCINOMA; MITOPHAGY; YAP;
D O I
10.18632/aging.103386
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Rho-associated kinase 1 (ROCK1) regulates tumor metastasis by maintaining cellular cytoskeleton homeostasis. However, the precise role of ROCK1 in non-small-cell lung cancer (NSCLC) apoptosis remains largely unknown. In this study, we examined the function of ROCK1 in NSCLS survival using RNA interference-mediated knockdown. Our results showed that ROCK1 knockdown reduced A549 lung cancer cell viability in vitro . It also inhibited A549 cell migration and proliferation. Transfection of ROCK1 siRNA was associated with increased expression of large tumor suppressor kinase 2 (LATS2) and c-Jun N-terminal kinase (JNK). Moreover, ROCK1 knockdown-induced A549 cell apoptosis and inhibition of proliferation were suppressed by LATS2 knockdown or JNK inactivation, suggesting that ROCK1 deficiency triggers NSCLC apoptosis in a LATS2-JNK pathway- dependent manner. Functional analysis further demonstrated that ROCK1 knockdown dysregulated mitochondrial dynamics and inhibited mitochondrial biogenesis. This effect too was reversed by LATS2 knockdown or JNK inactivation. We have thus identified a potential pathway by which ROCK1 downregulation triggers apoptosis in NSCLC by inducing LATS2-JNK-dependent mitochondrial damage.
引用
收藏
页码:12160 / 12174
页数:15
相关论文
共 50 条
  • [1] CALCR knockdown inhibits the development and progression of non-small-cell lung cancer
    He, Tao
    Ling, Feng
    CARCINOGENESIS, 2021, 42 (11) : 1390 - 1398
  • [2] PMEPA1 facilitates non-small cell lung cancer progression via activating the JNK signaling pathway
    Tan, Benxu
    Chen, Yonghong
    Xia, Lei
    Yu, Xian
    Peng, Yuan
    Zhang, Xiaoyue
    Yang, Zhenzhou
    CANCER BIOMARKERS, 2021, 31 (03) : 203 - 210
  • [3] Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer
    Hou, Xiao-Ming
    Baloch, Zulqarnain
    Zheng, Zhan-Hong
    Zhang, Wen-Hui
    Feng, Ying
    Li, Duan-Duan
    Wu, Xin-An
    Yang, Shi-Hua
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3275 - 3283
  • [4] FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway
    Meng, Wen
    Meng, Jingfei
    Jiang, Hong
    Feng, Xing
    Wei, Dongshan
    Ding, Qingsong
    ANALYTICAL CELLULAR PATHOLOGY, 2020, 2020
  • [5] Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway
    Wei, Chunli
    Yao, Xiaojun
    Jiang, Zebo
    Wang, Yuwei
    Zhang, Dianzheng
    Chen, Xi
    Fan, Xingxing
    Xie, Chun
    Cheng, Jingliang
    Fu, Junjiang
    Leung, Elaine Lai-Han
    PHARMACOLOGICAL RESEARCH, 2019, 144 : 79 - 89
  • [6] TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway
    Zhang, Ling-Xian
    Yang, Xin
    Wu, Zhi-Bo
    Liao, Zhong-Min
    Wang, Ding-Guo
    Chen, Shi-Wei
    Lu, Feng
    Wu, Yong-Bing
    Zhu, Shu-Qiang
    CANCER SCIENCE, 2023, 114 (03) : 855 - 869
  • [7] Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway
    Liu, Fujuan
    Liu, Tao
    Li, Haiying
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [8] Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway
    Fujuan Liu
    Tao Liu
    Haiying Li
    Cancer Cell International, 21
  • [9] RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer
    Xie, Shi-Yang
    Li, Guang
    Han, Chong
    Yu, Yang-Yang
    Li, Nan
    ONCOTARGETS AND THERAPY, 2017, 10 : 5605 - 5619
  • [10] Nrf2 regulates cell motility through RhoA–ROCK1 signalling in non-small-cell lung cancer cells
    Eunsun Ko
    Dasom Kim
    Dong Wha Min
    Seung-Hae Kwon
    Ji-Yun Lee
    Scientific Reports, 11